Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
For the sake of consistency and fairness: Why insurance companies should cover fertility preservation treatment for iatrogenic infertility
Lisa Campo-Engelstein
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'For the sake of consistency and fairness: Why insurance companies should cover fertility preservation treatment for iatrogenic infertility'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Assisted Reproductive Technology
100%
Boutique
20%
Elective Procedures
20%
Fertility Preservation Treatment
100%
Iatrogenic Infertility
100%
Infertility
40%
Insurance
60%
Insurance Companies
100%
Insurance Coverage
40%
Medical Illness
20%
Medical Treatment
20%
Strong Connections
20%
INIS
connections
14%
diseases
57%
fertility
100%
insurance
100%
medicine
14%
preservation
100%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Infertility
100%
Mathematics
Medical Treatment
100%
Real Disease
100%
Economics, Econometrics and Finance
Insurance Company
100%